David Page

h-index
h10-index
h5-index

Research activity per year

Fingerprint

Dive into the research topics where David Page is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

6 Active

A combined screening approach of Fracture (Fx) Risk Algorithm (FRAX) and Trabecular Bone Score (TBS) to identify osteoporotic-range fracture risk (ORFR) in breast cancer (BC) patients treated with adjuvant aromatase inhibitor (AI)
Page, D. (PI)
American Society of Clinical Oncology
01/1/15 → …
Project: Research
T-cell receptor DNA deep sequencing as a novel immune-based biomarker in early stage breast cancer.
Page, D. (PI)
01/1/15 → …
Project: Research
T-cell receptor DNA deep sequencing as a novel immune-based biomarker in early stage breast cancer
Page, D. (PI)
American Society of Clinical Oncology
01/1/15 → …
Project: Research
A combined screening approach of Fracture (Fx) Risk Algorithm (FRAX) and Trabecular Bone Score (TBS) to identify osteoporotic-range fracture risk (ORFR) in breast cancer (BC) patients treated with adjuvant aromatase inhibitor (AI).
Page, D. (PI)
Conquer Cancer Foundation
01/1/15 → …
Project: Research
Tumor and systemic immune responses to preoperative (pre-op) cryoablation (cryo) plus immune therapy with ipilimumab (ipi) in early-stage breast cancer (ESBC).
Page, D. (PI)
Conquer Cancer Foundation
01/1/14 → …
Project: Research

27 Article
17 Review article
11 Other contribution
3 Comment/debate
More
- 1 Editorial
- 1 Letter

Image-based multiplex immune profiling of cancer tissues: translational implications. A report of the International Immuno-oncology Biomarker Working Group on Breast Cancer
Jahangir, C. A., Page, D. B., Broeckx, G., Gonzalez, C. A., Burke, C., Murphy, C., Reis-Filho, J. S., Ly, A., Harms, P. W., Gupta, R. R., Vieth, M., Hida, A. I., Kahila, M., Kos, Z., van Diest, P. J., Verbandt, S., Thagaard, J., Khiroya, R., Abduljabbar, K. & Acosta Haab, G. & 117 others, Acs, B., Adams, S., Almeida, J. S., Alvarado-Cabrero, I., Azmoudeh-Ardalan, F., Badve, S., Baharun, N. B., Bellolio, E. R., Bheemaraju, V., Blenman, K. R. M., Botinelly Mendonça Fujimoto, L., Burgues, O., Chardas, A., Cheang, M. C. U., Ciompi, F., Cooper, L. A. D., Coosemans, A., Corredor, G., Dantas Portela, F. L., Deman, F., Demaria, S., Dudgeon, S. N., Elghazawy, M., Fernandez-Martín, C., Fineberg, S., Fox, S. B., Giltnane, J. M., Gnjatic, S., Gonzalez-Ericsson, P. I., Grigoriadis, A., Halama, N., Hanna, M. G., Harbhajanka, A., Hart, S. N., Hartman, J., Hewitt, S., Horlings, H. M., Husain, Z., Irshad, S., Janssen, E. A. M., Kataoka, T. R., Kawaguchi, K., Khramtsov, A. I., Kiraz, U., Kirtani, P., Kodach, L. L., Korski, K., Akturk, G., Scott, E., Kovács, A., Lænkholm, A. V., Lang-Schwarz, C., Larsimont, D., Lennerz, J. K., Lerousseau, M., Li, X., Madabhushi, A., Maley, S. K., Manur Narasimhamurthy, V., Marks, D. K., McDonald, E. S., Mehrotra, R., Michiels, S., Kharidehal, D., Minhas, F. U. A. A., Mittal, S., Moore, D. A., Mushtaq, S., Nighat, H., Papathomas, T., Penault-Llorca, F., Perera, R. D., Pinard, C. J., Pinto-Cardenas, J. C., Pruneri, G., Pusztai, L., Rajpoot, N. M., Rapoport, B. L., Rau, T. T., Ribeiro, J. M., Rimm, D., Vincent-Salomon, A., Saltz, J., Sayed, S., Hytopoulos, E., Mahon, S., Siziopikou, K. P., Sotiriou, C., Stenzinger, A., Sughayer, M. A., Sur, D., Symmans, F., Tanaka, S., Taxter, T., Tejpar, S., Teuwen, J., Thompson, E. A., Tramm, T., Tran, W. T., van der Laak, J., Verghese, G. E., Viale, G., Wahab, N., Walter, T., Waumans, Y., Wen, H. Y., Yang, W., Yuan, Y., Bartlett, J., Loibl, S., Denkert, C., Savas, P., Loi, S., Specht Stovgaard, E., Salgado, R., Gallagher, W. M. & Rahman, A., Mar 2024, In: Journal of Pathology. 262, 3, p. 271-288 18 p.
Research output: Contribution to journal › Review article › peer-review

Open Access
Preoperative immune checkpoint inhibition and cryoablation in early-stage breast cancer
Comen, E., Budhu, S., Elhanati, Y., Page, D., Rasalan-Ho, T., Ritter, E., Wong, P., Plitas, G., Patil, S., Brogi, E., Jochelson, M., Bryce, Y., Solomon, S. B., Norton, L., Merghoub, T. & McArthur, H. L., Feb 16 2024, In: iScience. 27, 2, 108880.
Research output: Contribution to journal › Article › peer-review

Open Access
1 Scopus citations
A phase Ib trial of pembrolizumab plus paclitaxel or flat-dose capecitabine in 1st/2nd line metastatic triple-negative breast cancer
Page, D. B., Pucilowska, J., Chun, B., Kim, I., Sanchez, K., Moxon, N., Mellinger, S., Wu, Y., Koguchi, Y., Conrad, V., Redmond, W. L., Martel, M., Sun, Z., Campbell, M. B., Conlin, A., Acheson, A., Basho, R., McAndrew, P., El-Masry, M. & Park, D. & 8 others, Bennetts, L., Seitz, R. S., Nielsen, T. J., McGregor, K., Rajamanickam, V., Bernard, B., Urba, W. J. & McArthur, H. L., Dec 2023, In: npj Breast Cancer. 9, 1, 53.
Research output: Contribution to journal › Article › peer-review

Open Access
2 Scopus citations
A phase II study of nivolumab plus ipilimumab and androgen receptor antagonist bicalutamide to stimulate thymic T cell generation in HER2-negative metastatic breast cancer
Page, D., Conlin, A., Stanton, S., Urba, W., Redmond, W. & comments, S. F. L. O. A. I., Dec 5 2023
Research output: Other contribution
Association of pathologic complete response with the 27-gene IO score and week 3 IOpath response following neoadjuvant pembrolizumab +/- intralymphatic cytokines in the neoIRX trial
Page, D., Redmond, W., Conlin, A., Stanton, S. & comments, S. F. L. O. A. I., Dec 5 2023
Research output: Other contribution

David Page, MD

Fingerprint

Collaborations and top research areas from the last five years

Dive into details

A combined screening approach of Fracture (Fx) Risk Algorithm (FRAX) and Trabecular Bone Score (TBS) to identify osteoporotic-range fracture risk (ORFR) in breast cancer (BC) patients treated with adjuvant aromatase inhibitor (AI)

T-cell receptor DNA deep sequencing as a novel immune-based biomarker in early stage breast cancer.

T-cell receptor DNA deep sequencing as a novel immune-based biomarker in early stage breast cancer

A combined screening approach of Fracture (Fx) Risk Algorithm (FRAX) and Trabecular Bone Score (TBS) to identify osteoporotic-range fracture risk (ORFR) in breast cancer (BC) patients treated with adjuvant aromatase inhibitor (AI).

Tumor and systemic immune responses to preoperative (pre-op) cryoablation (cryo) plus immune therapy with ipilimumab (ipi) in early-stage breast cancer (ESBC).

Image-based multiplex immune profiling of cancer tissues: translational implications. A report of the International Immuno-oncology Biomarker Working Group on Breast Cancer

Preoperative immune checkpoint inhibition and cryoablation in early-stage breast cancer

A phase Ib trial of pembrolizumab plus paclitaxel or flat-dose capecitabine in 1st/2nd line metastatic triple-negative breast cancer

A phase II study of nivolumab plus ipilimumab and androgen receptor antagonist bicalutamide to stimulate thymic T cell generation in HER2-negative metastatic breast cancer

Association of pathologic complete response with the 27-gene IO score and week 3 IOpath response following neoadjuvant pembrolizumab +/- intralymphatic cytokines in the neoIRX trial

David Page, MD

Fingerprint

Collaborations and top research areas from the last five years

Grants

Research Output